Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_2
2
67%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

recruiting133%
unknown267%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_2

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

NCT05316935
unknownnot_applicable

The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics

NCT04831151
unknownphase_2

A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS

NCT03264638

Clinical Trials (3)

Showing 3 of 3 trials
NCT05316935Phase 2

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Recruiting
NCT04831151Not Applicable

The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics

Unknown
NCT03264638Phase 2

A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3